Fourth quarter and full year 2019
Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
Fourth quarter and full year 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
I am encouraged by the fourth quarter results which position Sanofi to deliver on our new strategic priorities.
Chief Executive Officer